ChromaDex
CDXC
$3.30
Share price
-5.17%
Change (1 day)
112.90%
Change (1 year)
Categories
ChromaDex (CDXC) - P/B ratio
P/B ratio as of May 2024 : 9.24
According to ChromaDex's latest financial reports the company has a price-to-book ratio of 9.24.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
ChromaDex - P/B ratio (from 2008 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 3.78 | -13.48% |
| 2022-12-31 | 4.36 | -45.67% |
| 2021-12-31 | 8.03 | -55.59% |
| 2020-12-31 | 18.1 | 44.03% |
| 2019-12-31 | 12.6 | 80.6% |
| 2018-12-31 | 6.95 | 18.23% |
| 2017-12-31 | 5.88 | -53.25% |
| 2016-12-31 | 12.6 | -50.16% |
| 2015-12-31 | 25.2 | 7.12% |
| 2014-12-31 | 23.6 | -15.99% |
| 2013-12-31 | 28.0 | 129.32% |
| 2012-12-31 | 12.2 | -23.67% |
| 2011-12-31 | 16.0 | -3.34% |
| 2010-12-31 | 16.6 | 36.83% |
| 2009-12-31 | 12.1 | -37.18% |
| 2008-12-31 | 19.3 | |
| 2007-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Sangamo Therapeutics
SGMO | 1.52 | -83.50% | 🇺🇸 USA |
 Exelixis EXEL | 2.91 | -68.54% | 🇺🇸 USA |